Clinical trials
Active, not recruiting Phase 3 trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,237 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 6 |
| 2008 | 4 |
| 2009 | 5 |
| 2010 | 8 |
| 2011 | 11 |
| 2012 | 7 |
| 2013 | 11 |
| 2014 | 21 |
| 2015 | 30 |
| 2016 | 17 |
| 2017 | 45 |
| 2018 | 63 |
| 2019 | 82 |
| 2020 | 109 |
| 2021 | 164 |
| 2022 | 150 |
| 2023 | 170 |
| 2024 | 180 |
| 2025 | 123 |
| 2026 | 24 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 1,237 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 85 |
| National Cancer Institute (NCI) | 62 |
| Merck Sharp & Dohme LLC | 45 |
| Novartis Pharmaceuticals | 44 |
| Hoffmann-La Roche | 43 |
| Eli Lilly and Company | 41 |
| Janssen Research & Development, LLC | 37 |
| AbbVie | 29 |
| Pfizer | 26 |
| Amgen | 22 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 68 |
| Breast Neoplasms | 65 |
| Prostatic Neoplasms | 42 |
| Multiple Myeloma | 33 |
| Neoplasms | 33 |
| Obesity | 32 |
| Neoplasm Metastasis | 23 |
| Ovarian Neoplasms | 22 |
| Lung Neoplasms | 21 |
| Overweight | 21 |
Trials
Showing 1 to 25 of 1,237. Each trial links to its page on Pharma Observatory.
1,137 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.